Copyright ©2010 Baishideng.
World J Gastroenterol. May 14, 2010; 16(18): 2202-2222
Published online May 14, 2010. doi: 10.3748/wjg.v16.i18.2202
Table 6 Summary of recommendations for clinical use of S. boulardii in adults
Use for diseaseDose (mg/d)DurationAdjunct toStrength of evidence1
Prevention of antibiotic associated diarrhea500-1000During antibiotics with additional 3 d to 2 wk afterNothing++++
Prevention of Traveler’s diarrhea250-1000Duration of trip (3 wk)Nothing+++
Enteral nutrition-related diarrhea20008-28 dNothing++
H. pylori symptoms10002 wkStandard triple therapy++
Treatment of Clostridium difficile infections10004 wkVancomycin or metronidazole+
Acute adult diarrhea500-7508-10 dNothing+
Inflammatory bowel disease750-10007 wk to 6 moMesalamine+
Irritable bowel syndrome5004 wkNothing+
Giardiasis5004 wkMetronidazole+
HIV-related diarrhea30007 dNothing+